Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-22-059 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to establish a consortium of tuberculosis (TB) preclinical and clinical experts to systematically refine preclinical models by analyses of relevant pre-clinical and clinical data, and to provide results from optimized models to identify the most promising combination regimens for clinical testing
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding